Post-pandemic Era-Global Oncology Biosimilar Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2015-2026

Report ID: 256034 | Published Date: Jan 2025 | No. of Page: 112 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
Table of Contents

Global Oncology Biosimilar Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
    1.1 Product Details and Introduction
      1.1.1 Lung Cancer -Product Introduction and Major Manufacturers
      1.1.2 Colorectal Cancer -Product Introduction and Major Manufacturers
      1.1.3 Cervical Cancer -Product Introduction and Major Manufacturers
      1.1.4 Breast Cancer -Product Introduction and Major Manufacturers
      1.1.5 Kidney Cancer -Product Introduction and Major Manufacturers
      1.1.6 Stomach Cancer -Product Introduction and Major Manufacturers
      1.1.7 Brain Cancer -Product Introduction and Major Manufacturers
      1.1.8 Others -Product Introduction and Major Manufacturers
    1.2 Market Snapshot
      1.2.1 Major Companies Overview
      1.2.2 Market Concentration
      1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Oncology Biosimilar Market Assessment, by Segmentation
    2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026)
    2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026)
    2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026)
3 Regional Market Analysis
    3.1 China Oncology Biosimilar Market
      3.1.1 Top Companies leading Oncology Biosimilar Development in China (2015-2020)
      3.1.2 Sales Value of Major Company in China Market (2015-2020)
      3.1.3 China Oncology Biosimilar Price (USD/Unit), by Type (2019-2020)
      3.1.4 Sales in China Market, by Type (2015-2026)
    3.2 EU Oncology Biosimilar Market
      3.2.1 Top Companies leading Oncology Biosimilar Development in EU (2015-2020)
      3.2.2 Sales Value of Major Company in EU Market (2015-2020)
      3.2.3 EU Oncology Biosimilar Price (USD/Unit), by Type (2019-2020)
      3.2.4 Sales in EU Market, by Type (2015-2026)
    3.3 USA Oncology Biosimilar Market
      3.3.1 Top Companies leading Oncology Biosimilar Development in USA (2015-2020)
      3.3.2 Sales Value of Major Company in USA Market (2015-2020)
      3.3.3 USA Oncology Biosimilar Price (USD/Unit), by Type (2019-2020)
      3.3.4 Sales in USA Market, by Type (2015-2026)
    3.4 Japan Oncology Biosimilar Market
      3.4.1 Top Companies leading Oncology Biosimilar Development in Japan (2015-2020)
      3.4.2 Sales Value of Major Company in Japan Market (2015-2020)
      3.4.3 Japan Oncology Biosimilar Price (USD/Unit), by Type (2019-2020)
      3.4.4 Sales in Japan Market, by Type (2015-2026)
    3.5 India Oncology Biosimilar Market
      3.5.1 Top Companies leading Oncology Biosimilar Development in India (2015-2020)
      3.5.2 Sales Value of Major Company in India Market (2015-2020)
      3.5.3 India Oncology Biosimilar Price (USD/Unit), by Type (2019-2020)
      3.5.4 Sales in India Market, by Type (2015-2026)
    3.6 Southeast Asia Oncology Biosimilar Market
      3.6.1 Top Companies leading Oncology Biosimilar Development in Southeast Asia (2015-2020)
      3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020)
      3.6.3 Southeast Asia Oncology Biosimilar Price (USD/Unit), by Type (2019-2020)
      3.6.4 Sales in Southeast Asia Market, by Type (2015-2026)
    3.7 South America Oncology Biosimilar Market
      3.7.1 Top Companies leading Oncology Biosimilar Development in South America (2015-2020)
      3.7.2 Sales Value of Major Company in South America Market (2015-2020)
      3.7.3 South America Oncology Biosimilar Price (USD/Unit), by Type (2019-2020)
      3.7.4 Sales in South America Market, by Type (2015-2026)
4 Value Chain (Impact of COVID-19)
    4.1 Oncology Biosimilar Value Chain Analysis
      4.1.1 Upstream
      4.1.2 Downstream
    4.2 COVID-19 Impact on Oncology Biosimilar Industry
      4.2.1 Industrial Policy Issued Under the Epidemic Situation
    4.3 Cost-Under the Epidemic Situation
      4.3.1 Cost of Raw Material
    4.4 Channel Analysis
      4.4.1 Distribution Channel-Under the Epidemic Situation
      4.4.2 Distributors
5 Regional Market Forecast (2021-2026)
    5.1 Global Oncology Biosimilar Sales and Growth Rate (2021-2026)
    5.2 Global Oncology Biosimilar Sales Value and Growth Rate (2021-2026)

6 Oncology Biosimilar Competitive Analysis
     6.1 Biocon
        6.1.1 Biocon Company Profiles
        6.1.2 Biocon Product Introduction
        6.1.3 Biocon Oncology Biosimilar Production, Revenue (2015-2020)
        6.1.4 SWOT Analysis
     6.2 Celltrion Inc.
        6.2.1 Celltrion Inc. Company Profiles
        6.2.2 Celltrion Inc. Product Introduction
        6.2.3 Celltrion Inc. Oncology Biosimilar Production, Revenue (2015-2020)
        6.2.4 SWOT Analysis
     6.3 Dr. Reddy's Laboratories
        6.3.1 Dr. Reddy's Laboratories Company Profiles
        6.3.2 Dr. Reddy's Laboratories Product Introduction
        6.3.3 Dr. Reddy's Laboratories Oncology Biosimilar Production, Revenue (2015-2020)
        6.3.4 SWOT Analysis
     6.4 Intas Pharmaceuticals Ltd.
        6.4.1 Intas Pharmaceuticals Ltd. Company Profiles
        6.4.2 Intas Pharmaceuticals Ltd. Product Introduction
        6.4.3 Intas Pharmaceuticals Ltd. Oncology Biosimilar Production, Revenue (2015-2020)
        6.4.4 SWOT Analysis
     6.5 STADA Arzneimittel AG
        6.5.1 STADA Arzneimittel AG Company Profiles
        6.5.2 STADA Arzneimittel AG Product Introduction
        6.5.3 STADA Arzneimittel AG Oncology Biosimilar Production, Revenue (2015-2020)
        6.5.4 SWOT Analysis
     6.6 Pfizer Inc.
        6.6.1 Pfizer Inc. Company Profiles
        6.6.2 Pfizer Inc. Product Introduction
        6.6.3 Pfizer Inc. Oncology Biosimilar Production, Revenue (2015-2020)
        6.6.4 SWOT Analysis
     6.7 Apotex Inc.
        6.7.1 Apotex Inc. Company Profiles
        6.7.2 Apotex Inc. Product Introduction
        6.7.3 Apotex Inc. Oncology Biosimilar Production, Revenue (2015-2020)
        6.7.4 SWOT Analysis
     6.8 Teva Pharmaceutical Industries Ltd.
        6.8.1 Teva Pharmaceutical Industries Ltd. Company Profiles
        6.8.2 Teva Pharmaceutical Industries Ltd. Product Introduction
        6.8.3 Teva Pharmaceutical Industries Ltd. Oncology Biosimilar Production, Revenue (2015-2020)
        6.8.4 SWOT Analysis
     6.9 Sandoz International GmbH
        6.9.1 Sandoz International GmbH Company Profiles
        6.9.2 Sandoz International GmbH Product Introduction
        6.9.3 Sandoz International GmbH Oncology Biosimilar Production, Revenue (2015-2020)
        6.9.4 SWOT Analysis
     6.10 BIOCAD
        6.10.1 BIOCAD Company Profiles
        6.10.2 BIOCAD Product Introduction
        6.10.3 BIOCAD Oncology Biosimilar Production, Revenue (2015-2020)
        6.10.4 SWOT Analysis
     6.11 Mylan
     6.12 F Hoffmann-La Roche
7 Conclusion


List of Tables and Figures

    Figure Product Introduction
    Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020)
    Figure Global Oncology Biosimilar Production Market Share of Top 5 Players
    Table CAGR of Major Market (2021-2026)
    Table CAGR in Terms of Production of Each Type (2015-2026)
    Table CAGR in Terms of Production of Each Application (2015-2026)
    Table Global Oncology Biosimilar Sales (K Unit) by Type (2015-2026)
    Figure Global Oncology Biosimilar Sales (K Unit) and Growth Rate (2015-2026)
    Figure Global Oncology Biosimilar Sales Market Share (%) by Type (2019 -2020)
    Table Global Oncology Biosimilar Sales Value (Million USD) by Type (2015-2026)
    Figure Global Oncology Biosimilar Sales Value (Million USD) and Growth Rate (2015-2026)
    Figure Global Oncology Biosimilar Sales Value Market Share (%) by Type (2019-2020)
    Table Global Oncology Biosimilar Sales (K Unit) by Application (2015-2026)
    Table China Oncology Biosimilar Sales (K Unit) of Major Company (2015-2020)
    Table China Oncology Biosimilar Sales Market Share of Major Company (2015-2020)
    Table China Oncology Biosimilar Sales Value (Million USD) of Major Company (2015-2020)
    Figure China Oncology Biosimilar Sales Value (Million USD) and Growth Rate (2015-2020)
    Table China Oncology Biosimilar Sales Value Share of Major Company (2015-2020)
    Table China Oncology Biosimilar Price (USD/Unit), by Type (2019-2020)
    Table China Oncology Biosimilar Sales (Unit) by Type (2015-2026)
    Figure China Oncology Biosimilar Sales (Unit) by Type (2015-2026)
    Table EU Oncology Biosimilar Sales (K Unit) of Major Company (2015-2020)
    Table EU Oncology Biosimilar Sales Market Share of Major Company (2015-2020)
    Table EU Oncology Biosimilar Sales Value (Million USD) of Major Company (2015-2020)
    Figure EU Oncology Biosimilar Sales Value (Million USD) and Growth Rate (2015-2020)
    Table EU Oncology Biosimilar Sales Value Share of Major Company (2015-2020)
    Table EU Oncology Biosimilar Price (USD/Unit), by Type (2019-2020)
    Table EU Oncology Biosimilar Sales (Unit) by Type (2015-2026)
    Figure EU Oncology Biosimilar Sales (Unit) by Type (2015-2026)
    Table USA Oncology Biosimilar Sales (K Unit) of Major Company (2015-2020)
    Table USA Oncology Biosimilar Sales Market Share of Major Company (2015-2020)
    Table USA Oncology Biosimilar Sales Value (Million USD) of Major Company (2015-2020)
    Figure USA Oncology Biosimilar Sales Value (Million USD) and Growth Rate (2015-2020)
    Table USA Oncology Biosimilar Sales Value Share of Major Company (2015-2020)
    Table USA Oncology Biosimilar Price (USD/Unit), by Type (2019-2020)
    Table USA Oncology Biosimilar Sales (Unit) by Type (2015-2026)
    Figure USA Oncology Biosimilar Sales (Unit) by Type (2015-2026)
    Table Japan Oncology Biosimilar Sales (K Unit) of Major Company (2015-2020)
    Table Japan Oncology Biosimilar Sales Market Share of Major Company (2015-2020)
    Table Japan Oncology Biosimilar Sales Value (Million USD) of Major Company (2015-2020)
    Figure Japan Oncology Biosimilar Sales Value (Million USD) and Growth Rate (2015-2020)
    Table Japan Oncology Biosimilar Sales Value Share of Major Company (2015-2020)
    Table Japan Oncology Biosimilar Price (USD/Unit), by Type (2019-2020)
    Table Japan Oncology Biosimilar Sales (Unit) by Type (2015-2026)
    Figure Japan Oncology Biosimilar Sales (Unit) by Type (2015-2026)
    Table India Oncology Biosimilar Sales (K Unit) of Major Company (2015-2020)
    Table India Oncology Biosimilar Sales Market Share of Major Company (2015-2020)
    Table India Oncology Biosimilar Sales Value (Million USD) of Major Company (2015-2020)
    Figure India Oncology Biosimilar Sales Value (Million USD) and Growth Rate (2015-2020)
    Table India Oncology Biosimilar Sales Value Share of Major Company (2015-2020)
    Table India Oncology Biosimilar Price (USD/Unit), by Type (2019-2020)
    Table India Oncology Biosimilar Sales (Unit) by Type (2015-2026)
    Figure India Oncology Biosimilar Sales (Unit) by Type (2015-2026)
    Table Southeast Asia Oncology Biosimilar Sales (K Unit) of Major Company (2015-2020)
    Table Southeast Asia Oncology Biosimilar Sales Market Share of Major Company (2015-2020)
    Table Southeast Asia Oncology Biosimilar Sales Value (Million USD) of Major Company (2015-2020)
    Figure Southeast Asia Oncology Biosimilar Sales Value (Million USD) and Growth Rate (2015-2020)
    Table Southeast Asia Oncology Biosimilar Sales Value Share of Major Company (2015-2020)
    Table Southeast Asia Oncology Biosimilar Price (USD/Unit), by Type (2019-2020)
    Table Southeast Asia Oncology Biosimilar Sales (Unit) by Type (2015-2026)
    Figure Southeast Asia Oncology Biosimilar Sales (Unit) by Type (2015-2026)
    Table South America Oncology Biosimilar Sales (K Unit) of Major Company (2015-2020)
    Table South America Oncology Biosimilar Sales Market Share of Major Company (2015-2020)
    Table South America Oncology Biosimilar Sales Value (Million USD) of Major Company (2015-2020)
    Figure South America Oncology Biosimilar Sales Value (Million USD) and Growth Rate (2015-2020)
    Table South America Oncology Biosimilar Sales Value Share of Major Company (2015-2020)
    Table South America Oncology Biosimilar Price (USD/Unit), by Type (2019-2020)
    Table South America Oncology Biosimilar Sales (Unit) by Type (2015-2026)
    Figure South America Oncology Biosimilar Sales (Unit) by Type (2015-2026)
    Figure Value Chain Structure of Oncology Biosimilar
    Table Value Chain
    Table Key Suppliers of Raw Material/Components
    Table Key Downstream Customer in Each Application Field
    Table Industry News List of Oncology Biosimilar
    Figure Cost Structure of Oncology Biosimilar in 2020
    Table Distributors/Traders List
    Table Regional Market Sales (K Unit) (2021-2026)
    Table Regional Market Sales Share (2021-2026)
    Figure Global Oncology Biosimilar Sales (Unit), Growth Rate & Market Share (2021-2026)
    Table Regional Market Sales Value (Million USD) (2021-2026)
    Table Regional Market Sales Value Share (2021-2026)
    Figure Global Oncology Biosimilar Sales Value (Million USD), Growth Rate & Market Share (2021-2026)
    Table Biocon Profiles
    Table Biocon Oncology Biosimilar Product Introduction
    Table Biocon Oncology Biosimilar Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
    Figure Biocon SWOT Analysis
    Table Celltrion Inc. Profiles
    Table Celltrion Inc. Oncology Biosimilar Product Introduction
    Table Celltrion Inc. Oncology Biosimilar Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
    Figure Celltrion Inc. SWOT Analysis
    Table Dr. Reddy's Laboratories Profiles
    Table Dr. Reddy's Laboratories Oncology Biosimilar Product Introduction
    Table Dr. Reddy's Laboratories Oncology Biosimilar Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
    Figure Dr. Reddy's Laboratories SWOT Analysis
    Table Intas Pharmaceuticals Ltd. Profiles
    Table Intas Pharmaceuticals Ltd. Oncology Biosimilar Product Introduction
    Table Intas Pharmaceuticals Ltd. Oncology Biosimilar Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
    Figure Intas Pharmaceuticals Ltd. SWOT Analysis
    Table STADA Arzneimittel AG Profiles
    Table STADA Arzneimittel AG Oncology Biosimilar Product Introduction
    Table STADA Arzneimittel AG Oncology Biosimilar Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
    Figure STADA Arzneimittel AG SWOT Analysis
    Table Pfizer Inc. Profiles
    Table Pfizer Inc. Oncology Biosimilar Product Introduction
    Table Pfizer Inc. Oncology Biosimilar Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
    Figure Pfizer Inc. SWOT Analysis
    Table Apotex Inc. Profiles
    Table Apotex Inc. Oncology Biosimilar Product Introduction
    Table Apotex Inc. Oncology Biosimilar Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
    Figure Apotex Inc. SWOT Analysis
    Table Teva Pharmaceutical Industries Ltd. Profiles
    Table Teva Pharmaceutical Industries Ltd. Oncology Biosimilar Product Introduction
    Table Teva Pharmaceutical Industries Ltd. Oncology Biosimilar Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
    Figure Teva Pharmaceutical Industries Ltd. SWOT Analysis
    Table Sandoz International GmbH Profiles
    Table Sandoz International GmbH Oncology Biosimilar Product Introduction
    Table Sandoz International GmbH Oncology Biosimilar Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
    Figure Sandoz International GmbH SWOT Analysis
    Table BIOCAD Profiles
    Table BIOCAD Oncology Biosimilar Product Introduction
    Table BIOCAD Oncology Biosimilar Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
    Figure BIOCAD SWOT Analysis
    Table Mylan Profiles
    Table Mylan Oncology Biosimilar Product Introduction
    Table Mylan Oncology Biosimilar Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
    Figure Mylan SWOT Analysis
    Table F Hoffmann-La Roche Profiles
    Table F Hoffmann-La Roche Oncology Biosimilar Product Introduction
    Table F Hoffmann-La Roche Oncology Biosimilar Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2015-2020)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Post-pandemic Era-Global Oncology Biosimilar Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Post-pandemic Era-Global Oncology Biosimilar Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Post-pandemic Era-Global Oncology Biosimilar Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports